GPR156
gene geneOn this page
Also known as PGR28GABABL
Summary
GPR156 (G protein-coupled receptor 156, HGNC:20844) is a protein-coding gene on chromosome 3q13.33, encoding Probable G-protein coupled receptor 156 (Q8NFN8). Orphan G-protein coupled receptor involved in the regulation of hair cell orientation in mechanosensory organs of the inner ear.
G protein-coupled receptors (GPCRs) are a large superfamily of cell surface receptors characterized by 7 helical transmembrane domains, together with N-terminal extracellular and C-terminal intracellular domains.
Source: NCBI Gene 165829 — RefSeq curated summary.
At a glance
- Gene–disease (curated): hearing loss, autosomal recessive 121 (Strong, GenCC)
- GWAS associations: 6
- Clinical variants (ClinVar): 138 total — 3 likely-pathogenic
- Phenotypes (HPO): 6
- Druggable target: yes
- MANE Select transcript:
NM_153002
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20844 |
| Approved symbol | GPR156 |
| Name | G protein-coupled receptor 156 |
| Location | 3q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PGR28, GABABL |
| Ensembl gene | ENSG00000175697 |
| Ensembl biotype | protein_coding |
| OMIM | 610464 |
| Entrez | 165829 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000461057, ENST00000464295, ENST00000481907, ENST00000495912, ENST00000932327, ENST00000932328
RefSeq mRNA: 2 — MANE Select: NM_153002
NM_001168271, NM_153002
CCDS: CCDS2997, CCDS54629
Canonical transcript exons
ENST00000464295 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001235306 | 120181125 | 120181361 |
| ENSE00001235315 | 120185299 | 120185394 |
| ENSE00001235326 | 120186658 | 120186783 |
| ENSE00001235337 | 120192939 | 120193049 |
| ENSE00001235346 | 120193295 | 120193424 |
| ENSE00001775238 | 120243640 | 120243776 |
| ENSE00001924602 | 120285029 | 120285222 |
| ENSE00001935064 | 120165478 | 120168384 |
| ENSE00003487769 | 120173312 | 120173470 |
| ENSE00003496201 | 120244003 | 120244478 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 92.18.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1021 / max 15.4988, expressed in 27 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 44050 | 0.0847 | 19 |
| 44051 | 0.0174 | 5 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 92.18 | gold quality |
| pancreatic ductal cell | CL:0002079 | 87.21 | silver quality |
| upper arm skin | UBERON:0004263 | 85.39 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 83.43 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 82.36 | gold quality |
| kidney epithelium | UBERON:0004819 | 81.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.96 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 78.67 | gold quality |
| ileal mucosa | UBERON:0000331 | 78.61 | silver quality |
| cerebellar vermis | UBERON:0004720 | 77.26 | gold quality |
| sperm | CL:0000019 | 76.64 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 76.26 | gold quality |
| quadriceps femoris | UBERON:0001377 | 76.04 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 75.53 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.40 | gold quality |
| vastus lateralis | UBERON:0001379 | 74.49 | gold quality |
| endothelial cell | CL:0000115 | 74.22 | gold quality |
| body of tongue | UBERON:0011876 | 74.16 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 74.02 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 73.70 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 73.51 | gold quality |
| vena cava | UBERON:0004087 | 73.34 | gold quality |
| secondary oocyte | CL:0000655 | 73.33 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 73.29 | gold quality |
| cardia of stomach | UBERON:0001162 | 73.12 | gold quality |
| tongue | UBERON:0001723 | 73.09 | gold quality |
| thymus | UBERON:0002370 | 72.98 | gold quality |
| saphenous vein | UBERON:0007318 | 72.93 | gold quality |
| nipple | UBERON:0002030 | 72.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.73 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CTCF
miRNA regulators (miRDB)
72 targeting GPR156, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-5003-5P | 99.61 | 69.13 | 1624 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-548AV-3P | 99.43 | 68.50 | 1721 |
| HSA-MIR-4480 | 99.42 | 66.02 | 735 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-4291 | 99.20 | 68.88 | 2969 |
| HSA-MIR-3973 | 99.20 | 69.19 | 1990 |
| HSA-MIR-422A | 99.18 | 65.83 | 550 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
Literature-anchored findings (GeneRIF, showing 1)
- Novel GPR156 variants confirm its role in moderate sensorineural hearing loss. (PMID:37814107)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gpr156 | ENSDARG00000086215 |
| mus_musculus | Gpr156 | ENSMUSG00000046961 |
| rattus_norvegicus | Gpr156 | ENSRNOG00000002797 |
| drosophila_melanogaster | GABA-B-R2 | FBGN0027575 |
| caenorhabditis_elegans | WBGENE00022675 |
Paralogs (2): GABBR2 (ENSG00000136928), GABBR1 (ENSG00000204681)
Protein
Protein identifiers
Probable G-protein coupled receptor 156 — Q8NFN8 (reviewed: Q8NFN8)
Alternative names: G-protein coupled receptor PGR28, GABAB-related G-protein coupled receptor
All UniProt accessions (2): Q8NFN8, F8WAW3
UniProt curated annotations — full annotation on UniProt →
Function. Orphan G-protein coupled receptor involved in the regulation of hair cell orientation in mechanosensory organs of the inner ear. It is required to trigger a 180 degree reversal in hair cell orientation, creating a virtual line of polarity reversal (LPR) across which stereociliary bundles are arranged in opposite orientations.
Subcellular location. Cell membrane.
Tissue specificity. Ubiquitous expression both in the CNS and in peripheral tissues. Very high expression in fetal brain and testis relative to expression in other tissues.
Disease relevance. Deafness, autosomal recessive, 121 (DFNB121) [MIM:620551] A form of non-syndromic deafness characterized by congenital or prelingual onset of moderate sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the G-protein coupled receptor 3 family. GABA-B receptor subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NFN8-1 | 1 | yes |
| Q8NFN8-2 | 2 |
RefSeq proteins (2): NP_001161743, NP_694547* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002455 | GPCR3_GABA-B | Family |
| IPR017978 | GPCR_3_C | Domain |
| IPR041946 | GPR156_7TM | Domain |
Pfam: PF00003
UniProt features (52 total): helix 12, topological domain 8, compositionally biased region 8, transmembrane region 7, turn 4, strand 4, region of interest 3, sequence variant 2, chain 1, coiled-coil region 1, glycosylation site 1, splice variant 1
Structure
Experimental structures (PDB)
7 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8YK0 | ELECTRON MICROSCOPY | 2.4 |
| 8IEP | ELECTRON MICROSCOPY | 2.61 |
| 8IEI | ELECTRON MICROSCOPY | 2.62 |
| 8IEQ | ELECTRON MICROSCOPY | 2.73 |
| 8IEB | ELECTRON MICROSCOPY | 3.03 |
| 8YJP | ELECTRON MICROSCOPY | 3.09 |
| 8IED | ELECTRON MICROSCOPY | 3.33 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NFN8-F1 | 55.77 | 0.11 |
Antibody-complex structures (SAbDab): 1 — 8IED
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 6
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 61 (showing top):
GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY, GOBP_CELL_CELL_SIGNALING, CCANNAGRKGGC_UNKNOWN, TGIF_01, KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION, HP1SITEFACTOR_Q6, YNGTTNNNATT_UNKNOWN, GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX, GOCC_MEMBRANE_PROTEIN_COMPLEX, GOCC_RECEPTOR_COMPLEX, GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_GABA_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED
GO Biological Process (4): gamma-aminobutyric acid signaling pathway (GO:0007214), stereocilium bundle organization (GO:0160194), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (2): G protein-coupled GABA receptor activity (GO:0004965), G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (3): plasma membrane (GO:0005886), G protein-coupled receptor heterodimeric complex (GO:0038039), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| GABA receptor activity | 2 |
| G protein-coupled receptor activity | 2 |
| cell-cell signaling | 1 |
| cellular component organization | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| signal transduction | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| membrane | 1 |
| cell periphery | 1 |
| G protein-coupled receptor dimeric complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
586 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR156 | GPR158 | Q5T848 | 667 |
| GPR156 | GPRC5A | Q8NFJ5 | 580 |
| GPR156 | GPRC5B | Q9NZH0 | 528 |
| GPR156 | LRRC58 | Q96CX6 | 503 |
| GPR156 | GPRC5C | Q9NQ84 | 492 |
| GPR156 | GPSM2 | P81274 | 487 |
| GPR156 | GPRC5D | Q9NZD1 | 476 |
| GPR156 | GPRC6A | Q5T6X5 | 447 |
| GPR156 | GRIN2A | Q12879 | 431 |
| GPR156 | GRIN2B | Q13224 | 422 |
| GPR156 | GPR18 | Q14330 | 408 |
| GPR156 | ZC3H6 | P61129 | 404 |
| GPR156 | GABBR1 | Q9UBS5 | 375 |
| GPR156 | PRM3 | Q9NNZ6 | 371 |
| GPR156 | LYPD6B | Q8NI32 | 368 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPR156 | PLD2 | psi-mi:“MI:0914”(association) | 0.640 |
| GPR156 | RAMP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR156 | RAMP2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP3 | GPR156 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR156 | RAMP3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP1 | GPR156 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (129): ZNF564 (Affinity Capture-MS), RPUSD2 (Affinity Capture-MS), VANGL2 (Affinity Capture-MS), VANGL1 (Affinity Capture-MS), ZBTB1 (Affinity Capture-MS), ZNF444 (Affinity Capture-MS), NFKBIL1 (Affinity Capture-MS), AGAP3 (Affinity Capture-MS), PLD1 (Affinity Capture-MS), FARP2 (Affinity Capture-MS), SHQ1 (Affinity Capture-MS), MCRS1 (Affinity Capture-MS), PHTF2 (Affinity Capture-MS), PPP2R3B (Affinity Capture-MS), OBSL1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GV85, A2ALI5, A2APT9, B0BN44, B1ARY8, B6ZI38, O14836, O35188, O55145, O60279, O60667, P07141, P09603, P0C8S2, P28906, P40225, P40226, P42705, P78423, Q06154, Q08DV9, Q13261, Q1ERP8, Q28270, Q2TB54, Q3UY90, Q4V9H3, Q4W8E7, Q5F267, Q5R770, Q60819, Q64314, Q6PAL1, Q6PCP7, Q6UXB8, Q80XI1, Q8BLK9, Q8CAE9, Q8CBC4, Q8JZQ0
Diamond homologs: G5ECB2, O75899, O88871, Q6PCP7, Q80T41, Q8K451, Q8NFN8, Q9UBS5, Q9WV18, Q9Z0U4, O70410, P23385, P31421, P31422, P31424, P41594, P91685, P97772, Q09630, Q13255, Q14416, Q14832, Q14BI2, Q1ZZH1, Q3UVX5, Q54SW3, Q55AP3, Q5RAL3, Q5U9X3, Q9QYS2, P35349, Q863I4, Q1ZXQ7, Q54L53, Q54LG8, Q54SH7, Q54SH8, Q55AP1, Q75JP4, Q75JT4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
138 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 3 |
| Uncertain significance | 112 |
| Likely benign | 14 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3064875 | NM_153002.3(GPR156):c.1924del (p.Ser642fs) | Likely pathogenic |
| 4292205 | NM_153002.3(GPR156):c.696+1G>T | Likely pathogenic |
| 4685463 | NM_153002.3(GPR156):c.474+1del | Likely pathogenic |
SpliceAI
1957 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:120168380:TTTTT:T | acceptor_gain | 1.0000 |
| 3:120168381:TTTT:T | acceptor_gain | 1.0000 |
| 3:120168382:TTT:T | acceptor_gain | 1.0000 |
| 3:120168383:TT:T | acceptor_gain | 1.0000 |
| 3:120168383:TTCT:T | acceptor_loss | 1.0000 |
| 3:120168384:TCT:T | acceptor_loss | 1.0000 |
| 3:120168385:C:CC | acceptor_gain | 1.0000 |
| 3:120168385:C:CG | acceptor_loss | 1.0000 |
| 3:120168386:T:A | acceptor_loss | 1.0000 |
| 3:120173310:A:AC | donor_gain | 1.0000 |
| 3:120173311:C:CC | donor_gain | 1.0000 |
| 3:120173311:CTT:C | donor_gain | 1.0000 |
| 3:120173313:T:TA | donor_gain | 1.0000 |
| 3:120173466:TTCAG:T | acceptor_gain | 1.0000 |
| 3:120173467:TCAG:T | acceptor_gain | 1.0000 |
| 3:120173468:CAG:C | acceptor_gain | 1.0000 |
| 3:120173468:CAGC:C | acceptor_gain | 1.0000 |
| 3:120173469:AG:A | acceptor_gain | 1.0000 |
| 3:120173469:AGCT:A | acceptor_loss | 1.0000 |
| 3:120173470:GC:G | acceptor_loss | 1.0000 |
| 3:120173471:C:A | acceptor_loss | 1.0000 |
| 3:120173471:C:CC | acceptor_gain | 1.0000 |
| 3:120173472:T:C | acceptor_loss | 1.0000 |
| 3:120173474:T:C | acceptor_gain | 1.0000 |
| 3:120173474:T:TC | acceptor_gain | 1.0000 |
| 3:120186669:CA:C | donor_gain | 1.0000 |
| 3:120243997:A:AC | donor_gain | 1.0000 |
| 3:120243998:C:CC | donor_gain | 1.0000 |
| 3:120243998:CTTA:C | donor_gain | 1.0000 |
| 3:120243999:TTA:T | donor_loss | 1.0000 |
AlphaMissense
5308 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:120193373:A:C | S95R | 0.996 |
| 3:120193373:A:T | S95R | 0.996 |
| 3:120193375:T:G | S95R | 0.996 |
| 3:120192987:G:C | S142R | 0.995 |
| 3:120192987:G:T | S142R | 0.995 |
| 3:120192989:T:G | S142R | 0.995 |
| 3:120168362:A:G | L372P | 0.993 |
| 3:120193355:G:C | S101R | 0.993 |
| 3:120193355:G:T | S101R | 0.993 |
| 3:120193357:T:G | S101R | 0.993 |
| 3:120193406:A:C | S84R | 0.992 |
| 3:120193406:A:T | S84R | 0.992 |
| 3:120193408:T:G | S84R | 0.992 |
| 3:120168342:C:G | A379P | 0.990 |
| 3:120243699:G:C | S58R | 0.989 |
| 3:120243699:G:T | S58R | 0.989 |
| 3:120243701:T:G | S58R | 0.989 |
| 3:120192966:A:C | F149L | 0.988 |
| 3:120192966:A:T | F149L | 0.988 |
| 3:120192968:A:G | F149L | 0.988 |
| 3:120192990:C:A | K141N | 0.987 |
| 3:120192990:C:G | K141N | 0.987 |
| 3:120186773:T:G | D162A | 0.986 |
| 3:120186764:A:G | L165S | 0.985 |
| 3:120193378:C:G | G94R | 0.985 |
| 3:120193413:A:G | M82T | 0.984 |
| 3:120185325:A:G | W224R | 0.983 |
| 3:120185325:A:T | W224R | 0.983 |
| 3:120193377:C:T | G94D | 0.983 |
| 3:120168378:C:G | A367P | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000004877 (3:120228054 G>C), RS1000173064 (3:120280330 T>C), RS1000238094 (3:120251259 G>A), RS1000240026 (3:120169856 C>T), RS1000297867 (3:120243898 A>C,G), RS1000306744 (3:120197285 G>A), RS1000356211 (3:120184264 A>T), RS1000386118 (3:120283706 G>C), RS1000420885 (3:120190127 A>G), RS1000423670 (3:120261313 TAA>T), RS1000443053 (3:120170080 T>C), RS1000521613 (3:120227688 A>G), RS1000538731 (3:120247417 T>C), RS1000539103 (3:120230678 C>T), RS1000542313 (3:120205794 ATTAT>A)
Disease associations
OMIM: gene MIM:610464 | disease phenotypes: MIM:220290, MIM:607197, MIM:620551
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| hearing loss, autosomal recessive 121 | Strong | Autosomal recessive |
Mondo (2): hearing loss, autosomal recessive (MONDO:0019588), hearing loss, autosomal recessive 121 (MONDO:0957825)
Orphanet (2): Rare autosomal dominant non-syndromic sensorineural deafness type DFNA (Orphanet:90635), Rare autosomal recessive non-syndromic sensorineural deafness type DFNB (Orphanet:90636)
HPO phenotypes
6 total (6 of 6 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000545 | Myopia |
| HP:0001756 | Vestibular hyporeflexia |
| HP:0003577 | Congenital onset |
| HP:0011463 | Childhood onset |
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006993_4 | Hippocampal volume in Alzheimer’s disease dementia | 1.000000e-07 |
| GCST010107_12 | L-selectin levels | 8.000000e-06 |
| GCST011742_1 | Triglyceride levels in HIV infection | 9.000000e-06 |
| GCST011742_13 | Triglyceride levels in HIV infection | 9.000000e-06 |
| GCST012071_14 | Response to selenium supplementation (change in plasma selenium concentration) | 1.000000e-05 |
| GCST90011900_23 | Serum alkaline phosphatase levels | 1.000000e-12 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005035 | hippocampal volume |
| EFO:0008202 | L-Selectin measurement |
| EFO:0004530 | triglyceride measurement |
| EFO:0600021 | response to dietary selenium supplementation |
| EFO:0004533 | alkaline phosphatase measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C564609 | Deafness, Autosomal Recessive (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523897 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class C Orphans
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| bisphenol A | increases methylation | 1 |
| sodium arsenite | affects binding, increases reaction | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects cotreatment, affects response to substance | 1 |
| abrine | increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Methapyrilene | increases methylation | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883423 | Binding | PRESTO-Tango GPCRome screening (GPR156) | Data for DCP probe UCSF924 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: hearing loss, autosomal recessive 121
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hearing loss, autosomal recessive 121